Disability pension among patients undergoing coronary revascularisation by Zetterström, Katharina
 
 
From The Department of Clinical Neuroscience,  
Division of Insurance Medicine 
Karolinska Institutet, Stockholm, Sweden 
DISABILITY PENSION 
AMONG PATIENTS UNDERGOING 
CORONARY REVASCULARISATION 
 
Katharina Zetterström 
 
Stockholm 2015 
 
 All previously published papers were reproduced with permission from the publisher. 
Published by Karolinska Institutet. Printed by E-Print AB 2015 
 
© Katharina Zetterström, 2015 
ISBN 978-91-7549-975-8 
 
 
Disability pension among patients undergoing coronary 
revascularisation 
THESIS FOR DOCTORAL DEGREE (Ph.D.) 
By 
Katharina Zetterström 
 
Principal Supervisor: 
Professor Kristina Alexanderson 
Karolinska Institutet 
Department of Clinical Neuroscience 
Division of Insurance Medicine 
 
Co-supervisors: 
Associate Professor Marjan Vaez 
Karolinska Institutet 
Department of Clinical Neuroscience 
Division of Insurance Medicine 
 
Associate Professor Margaretha Voss 
Karolinska Institutet 
Department of Clinical Neuroscience 
Division of Insurance Medicine 
Opponent: 
Professor Emeritus Kurt Svärdsudd 
Uppsala University 
Department of Public Health and Caring Sciences 
Division of Family Medicine and Preventive 
Medicine 
 
Examination Board: 
Professor Karin Schenck-Gustafsson 
Karolinska Institutet 
Department of Medicine  
Division of Centre for Gender Medicine 
 
Professor Nina Rehnqvist Ahlberg 
Karolinska Institutet 
Department of Medicine 
Division of Cardiology 
 
Professor Britt Östlund 
KTH Royal Institute of Technology 
Department of School of Technology and Health 
 
 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
“Give me a place to stand and I will move the earth” 
(Archimedes) 
  
Abstract 
Background: Cardiovascular disease (CVD) is the main cause of death both in Sweden as 
well as globally, and represents a major public health problem also regarding impaired 
physical capacity and work disability. After musculoskeletal and mental diagnoses CVD is 
the third largest diagnostic group for disability pension (DP) in Sweden. Annually about 
10 000 working-aged individuals undergo coronary revascularisation, i.e., coronary artery 
bypass grafting (CABG) or percutaneous coronary intervention (PCI). These are established 
and well-documented interventions, resulting in symptom reduction, improved physical 
capacity, and among some patient groups, lower mortality. Coronary revascularisation could, 
hence, prevent early labour market exit. However, scientific knowledge is scarce regarding 
DP among patients with coronary revascularisation. The aim was to study general and 
diagnosis-specific DP, and its association with all-cause and CVD mortality among working-
aged women and men with a first coronary revascularisation in 1994-2006, accounting for 
socio-demographic and medical factors. 
Methods: Nationwide, population-based, cross-sectional and prospective cohort register 
studies were conducted. All, 78 153 patients, 30-65 years of age at time of their first coronary 
revascularisation in 1994-2006 in Sweden, were identified using the SWEDEHEART 
register, with information on all such interventions as well as patient characteristics, 
indication, date and type of intervention, and diabetes. Information on socio-demographic and 
medical factors was linked at individual level from nationwide registers held by the Social 
Insurance Agency, the National Board of Health and Welfare, and the Statistics Sweden. 
Logistic regression analyses were performed to estimate the probability of being on DP at the 
time of a first intervention (study I) and Cox regression analyses were performed to estimate 
the risk of being granted DP (study II), or the risk of all-cause mortality (study III) or all-
cause and CVD mortality (study IV) within five years following a first intervention. 
Results: At the time of the coronary revascularisation, 24% were on DP; sixty two percent 
had been on DP for at least four years before intervention. The largest DP-diagnostic group 
was musculoskeletal diagnoses. The odds ratio for DP was higher among: CABG-patients, 
women, older individuals, lower level educated, foreign-born, individuals living in smaller 
communities and individuals with another indication for PCI than acute coronary syndrome 
or stable angina pectoris (study I). Within five years following the intervention, 32% had 
been granted DP. The hazard ratio for DP was higher among: CABG-patients, women, 
individuals with in-patient care for mental diagnoses (except for women, CABG), or 
musculoskeletal diagnoses in the five years before the intervention, with ≥180 sick-leave days 
in the year before the intervention, with diabetes at the intervention, and individuals with ≥1 
re-intervention within the five following years (study II). Four percent died within five years 
following coronary revascularisation, most due to CVD. DP at the time of the intervention 
was associated with higher risks of mortality five years following intervention (study III). 
The mortality risk was higher among all the studied DP-diagnostic groups (CVD, 
musculoskeletal, and mental diagnoses) compared with no DP at the time of the intervention, 
and did not differ between the DP diagnoses (study IV). 
Conclusions: A quarter of the patients already had DP at the time of CABG or PCI, a 
majority for at least 4 years before the intervention. In addition, the largest DP-diagnostic 
group was musculoskeletal diagnoses. One third was granted DP within a five-year follow-
up. The mortality risk was higher both with all-cause and diagnosis-specific DP which could 
not be explained by the studied socio-demographic and medical factors. No differences in 
mortality were found between most of the studied DP-diagnostic groups; also 
musculoskeletal diagnoses were associated with higher five-year mortality. More detailed 
knowledge regarding these associations is needed.  
 
 
Svensk sammanfattning 
Bakgrund: Hjärt-kärlsjukdom är den vanligaste dödsorsaken, både i Sverige och globalt, och 
utgör ett stort folkhälsoproblem även gällande försämrad fysisk kapacitet och arbetsförmåga. 
Efter muskuloskeletala och mentala diagnoser utgör hjärt-kärlsjukdom den tredje största 
diagnosgruppen för sjukersättning (DP) i Sverige. Årligen genomgår cirka 10 000 hjärt-
kärlsjuka individer under 65 års ålder en kranskärlsintervention av antingen koronar bypass-
kirurgi (CABG) eller perkutan kranskärlsintervention (PCI). Dessa är etablerade 
interventioner som resulterat i minskade symptom, förbättrad fysisk kapacitet och, bland 
vissa patientgrupper, lägre dödlighet. Dessa två interventioner skulle därför kunna förebygga 
ett förtidigt utträde ur arbetslivet. Dock är den vetenskapliga kunskapen begränsad gällande 
både prevalens och incidens av DP bland patienter med kranskärlsintervention. Syftet var att 
studera generell respektive diagnos-specifik DP samt dess samband med dödlighet (generell 
och på grund av hjärt-kärlsjukdom) bland kvinnor och män i arbetsför ålder vid en första 
kranskärlsintervention 1994-2006, justerat för sociodemografiska och medicinska faktorer. 
Metod: Populationsbaserade studier baserade på rikstäckande registerdata genomfördes; en 
tvärsnittsstudie och tre prospektiva kohortstudier. Sammanlagt genomgick 78 153 patienter 
under åren 1994-2006 en första kranskärlsintervention (CABG eller PCI) i Sverige när de var 
30-65 år gamla. De identifierades genom SWEDEHEART-registret, där även information om 
patientkarakteristika, indikation, datum och typ av intervention samt diabetes inhämtades. 
Länkad information om sociodemografiska och medicinska faktorer hämtades från 
Försäkringskassan, Socialstyrelsen och Statistiska centralbyrån. Logistiska 
regressionsanalyser genomfördes för att beräkna sannolikheten för DP vid interventionen 
(studie I). Cox regressionsanalyser genomfördes för att beräkna risk för framtida DP (studie 
II), generell dödlighet (studie III), samt generell och hjärt-kärl dödlighet (studie IV) inom fem 
år efter interventionen. 
Resultat: Vid kranskärlsinterventionen hade 24 % DP. Sextiotvå procent av dem hade haft 
DP sedan minst fyra år före intervention. Den största DP-diagnosgruppen var 
muskuloskeletala diagnoser. Sannolikheten för DP vid interventionen var högre bland: 
CABG-patienter, kvinnor, äldre individer, de med lägre utbildningsnivå, utrikesfödda, boende 
i mindre samhällen, samt de med annan indikation för PCI än akut kranskärlssjukdom eller 
kärlkramp (studie I). Totalt beviljades 32 % av de som inte hade DP, detta inom fem år efter 
interventionen. Risken för sådan DP var högre bland: CABG-patienter, kvinnor, de med 
slutenvård för mentala (förutom kvinnor, CABG) och/eller muskuloskeletala diagnoser inom 
fem år före intervention, de med ≥180 sjukfrånvarodagar tolv månader före intervention, de 
med diabetes vid intervention, samt de med minst en re-intervention inom fem år (studie II). 
Fyra procent avled inom fem år efter interventionen, de flesta på grund av hjärt-kärl sjukdom. 
DP vid interventionen var associerad med högre risk för död inom fem år (studie III). Risken 
för förtida död var högre bland samtliga av de studerade DP-diagnosgrupperna (hjärta-kärl, 
muskuloskeletala, och mentala diagnoser) jämfört med de utan DP vid interventionen. 
Resultaten var likartade mellan de flesta av DP-diagnosgrupperna (studie IV). 
Konklusion: En fjärdedel av de studerade patienterna hade redan DP vid sin första CABG 
eller PCI och majoriteten hade haft DP sedan minst fyra år före intervention. 
Muskuloskeletala diagnoser var den största DP-diagnosgruppen. En tredjedel beviljades DP 
inom fem år efter interventionen. De med DP vid interventionen hade högre risk att avlida 
inom fem år, jämfört med de utan DP. Denna risk var högre i samtliga av de studerade DP-
diagnosgrupperna. Den högre risken kvarstod trots justering för de inkluderade 
sociodemografiska och medicinska faktorerna. Inga skillnader fanns mellan de flesta 
studerade DP-diagnosgrupperna; även muskuloskeletala diagnoser var associerade med högre 
risk för död inom fem år efter interventionen. Mer detaljerad kunskap om dessa samband 
behövs som underlag för preventiva insatser. 
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1 Introduction 
This thesis concerns disability pension (DP) among patients, both women and men, in 
working ages, who had a first coronary revascularisation by either coronary artery bypass 
grafting (CABG) or percutaneous coronary intervention (PCI) in Sweden between the years 
1994-2003 (study II) or 1994-2006 (study I, III-IV). Each year many thousands of working 
aged patients (<65 years) undergo CABG or PCI in Sweden. These two interventions are well 
documented treatments for acute coronary syndrome (ACS) and angina pectoris (1-8). 
Cardiovascular disease (CVD) is a major public health issue, worldwide as well as in Sweden 
(9). CVD leads to impaired physical capacity, work disability, and mortality, and is the 
number one cause of death globally, for both women and men. In Sweden, CVD constitutes 
the third largest diagnostic groups for DP, after mental and musculoskeletal DP diagnoses (10, 
11). In 2003, the Swedish Council on Technology Assessment in Health Care (SBU) (12) 
concluded that research about sickness absence and DP is very limited and that more 
scientific knowledge is needed regarding DP both in general (11, 13) as well as for CVD (14). 
There are only few studies about sickness absence or DP and CVD, including coronary 
interventions, especially considering the magnitude of the problem both for society, health 
care and individuals (14). The few conducted studies are based on smaller samples, the data is 
seldom presented for both women and men, and some only include CABG-patients (14-18). 
More comprehensive studies including larger populations are needed to investigate DP 
among patients, both women and men, with a first coronary revascularisation by type of 
intervention. Such studies should focus on risk indicators of early exit from the labour market 
and to further develop strategies for preventive measures among women and men with 
coronary revascularisation by CABG or PCI, in higher risk for DP. 
1.1 Cardiovascular disease 
Cardiovascular disease (CVD), including coronary heart disease (CHD) is a group of 
disorders involving the heart and the blood vessels. CVD is the main cause of death 
worldwide (19). Globally, a total of 17.5 million individuals died in CVD during 2012; of 
these, 7.4 million died due to CHD. Also in Sweden, the study setting of this thesis, CVD 
constitutes the main cause of death (20). In 2010, about 40% of all mortality among women 
and men were caused by CVD (21). There are gender differences in CVD; women get the 
symptoms later in life, and are older at the onset of their diagnosis (22-24). In 2010-2012 in 
Sweden, 67% of the women and 43% of the men were 75 years or older at the onset of their 
first myocardial infarction (MI) (25). Moreover, women have smaller coronary arteries and 
more co-morbidity than men (2). These facts might explain previous study findings of higher 
short-term mortality (26) and lower long-term mortality risk (26-29) among women compared to 
among men. During the last decades the number of deaths caused by CVD has declined (20) 
The number of MIs has, however, foremost decreased among older individuals. Among 
younger women (45-64 years) there have been no decreases in MIs since the 1990s. 
There are several known risk factors for CVD. Age, gender, and family history are non-
modifiable factors. However, many other established risk factors are modifiable and can thus 
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be controlled, treated, or modified. Examples of such risk factors are: hypertension, raised 
blood glucose level (diabetes mellitus), and hyperlipidaemia, as well as lifestyle factors as 
tobacco use, harmful use of alcohol, unhealthy diet, obesity, physical inactivity, etcetera (9). 
Socio-demographic factors, such as low socio-economic position e.g., regarding educational 
level, employment status, and financial situation, may also increase the risk of CVD (5, 30, 31). 
1.1.1 Coronary revascularisation 
Annually in Sweden, about 10 000 patients of working age (<65 years), with stable effort 
angina pectoris or acute coronary syndrome (ACS), i.e., ST-elevation myocardial infarction 
and non-ST elevation myocardial infarction, undergo coronary revascularisation by either 
CABG or PCI. A majority of these patients are men.  
1.1.1.1 Coronary artery bypass grafting (CABG) 
CABG is an invasive technique performed to bypass the obstructed coronary artery with a 
shunt of a vein or an artery to improve the blood supply oxygen to the ischemic myocardium.  
The chest has to be opened and grafts harvested from the leg. Usually CABG requires use of 
a heart- and lung machine.  
1.1.1.2 Percutaneous coronary intervention (PCI) 
PCI is a much less invasive procedure. It involves catheter dilation of the diseased coronary 
artery by an inflatable ‘balloon’ and the placing of a stent in the narrowed or blocked blood 
vessel, so that the blood can pass. The artery is reached, using fine instruments administrated 
through artery after puncture of an artery in the groin or more and more frequently at the 
wrist. Therefore, the recovery time after PCI is shorter than after the more invasive CABG 
why PCI nowadays often is a first-hand choice. The method is e.g., used among patients with 
uncomplicated coronary obstruction.  
CABG and PCI are established and well documented treatments for these conditions (1, 2, 4-8). 
To a high degree these interventions result in relive of symptoms, improved physical 
capacity, and in some subgroups of patients, reduced mortality (6). Since the 1980’s, the 
number of PCIs has increased continuously, and has, for some patient categories replaced 
CABG. This has led to a considerable shift of the population undergoing CABG to an 
increased proportion with multi-vessel and more severe coronary artery disease (14, 32). It is, 
however, more usual that patients have recurrence of symptoms, after PCI than after CABG 
and require repeated intervention.   
1.1.2 Information on CABG and PCI 
As CVD is a major public health issue, much health care concerns treatment of CVD patients. 
Different strategies to acquire more and better knowledge on effects of various treatments 
have been introduced over the last decades. Several nationwide registers regarding this 
patient group have been established by clinicians in Sweden. These registers are called 
‘quality registers’ as the purpose is to contribute to improvement of health care quality (33).  
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1.1.2.1 SWEDEHEART 
The patients included in this thesis were identified using the nationwide SWEDHEART 
register (3, 34). This comprehensive register includes data from three registers that were 
merged in December 2009, namely the Swedish Heart Surgery Register, SCAAR, and RIKS-
HIA; described more in detail below. These registers cover all the 73 hospitals with heart 
intensive care in Sweden. Information about all CABG procedures is complete from 1992. 
The aim of the SWEDEHEART register is to provide a basis for studies that can lead to 
improvement of the quality of care of patients with CVD and to constitute a platform for 
scientific research on CVD. The long-term goal is to contribute to reduced morbidity and 
mortality among patients with cardiac disease and to improve cost-effectiveness in health 
care. The SWEDHEART register includes information about a large number of variables for 
each registered patient. The registration is performed both at the time of hospital care, at 
cardiac interventions, and for some patients at revisits at eight weeks and one year following 
the treatment. The reporting is conducted on-line through the SWEDEHEART’s web-based 
program. Annual reports are published on-line. The SWEDEHEART register has also been 
utilised for evaluation of treatment strategies and has through scientifically international 
reports contributed to an improved cardiovascular health care worldwide, reducing 
complication rates and mortality (3, 34). Below some more information about the registers in 
SWEDHEART is given. 
1. The Swedish Heart Surgery Register has, from the start in 1992, included information on 
all heart surgeries performed in Sweden. The register includes all patients who have had 
CABG with information on: date and type of intervention and indication as well as patients’ 
age, sex, length, weight, and date of death. A risk profile of each patient can be identified 
using the Euro score based on 18 patient-related variables (34). 
2. The Swedish Coronary Angiography and Angioplasty Registry (SCAAR) was established in 
1998, and was in 2001 connected to the Uppsala Clinical Research Centre (UCR) (34).  
3. The register of Information and Knowledge about Swedish Heart Intensive Care 
Admissions (RIKS-HIA), was established in 1995. It includes information on cardiac care 
before and following the cardiac interventions. All the included hospitals had coverage of 
95% of the patients in 2001 and of 100% in 2008 (34). 
1.2 Disability pension 
Now as well as during the period studied (1994-2007) in this thesis, the public social 
insurance system (35), covering all residents in Sweden aged 19-65 years, involves the 
possibility to be granted disability pension (DP) benefits. DP can be granted individuals with 
a disease or an injury that has led to long-time or permanent reduction of work capacity in 
relation to the demands of ordinary work at the labour market (35). DP can be granted for full 
or part time of ordinary working hours. For individuals with no, or a low previous work 
income, the DP benefits amount to a minimum level. Those with a previous income could be 
granted benefit for at least 64% of lost income, up to a certain level. The Social Insurance 
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Agency officers decide if a claimant fulfils the criteria for being granted DP. That decision is 
based on medical assessments regarding the diagnoses, the limitations in function that the 
diagnoses have led to, and to what extent this impairs activity and work capacity. During the 
years studied it was possible to be granted temporary DP, for one or several years. Individuals 
with income from work or unemployment benefits were generally on sickness absence for at 
least 12 months before being granted DP (36). 
In Sweden, the general age for old-age pension is 65 years. Old-age pension can be taken 
later or earlier, e.g., from 61 years of age – individuals on early old-age pension cannot be 
granted DP even if they are not 65 years old. 
1.2.1 Prevalence and incidence of disability pension 
In this thesis the prevalence and incidence of DP as well as mortality among patients on DP, 
and not on DP at time of a first coronary revascularisation were studied. Prevalence data 
contributes with information on a specific number of individuals that (in this case) are on DP, 
at a specific given time point or period of time, and are therefore valuable for estimating the 
proportions of individuals receiving DP at a certain time point, in a certain population, in this 
case among patients with a first coronary revascularisation. Incidence data involves 
information of new cases, here, the rates of new individuals being granted DPs, per individual 
at risk in a given time period. 
This thesis includes studies investigating either DP at the time of coronary revascularisation 
(in 1994-2006) or granted DP five years following the CABG or PCI (up through year 2007) 
among working-aged (30-64 years) women and men. During this period, the annual DP rate, 
among the general population, increased from about 8% in 1990 to about 10% in 2007 (36). At 
the end of the studied period (in 2007) a total of 524 827 women and men, aged 30-64 years 
were on DP in Sweden. Hence, in 2007 about 12.3% of all working-aged women and men 
had left the labour market early due to DP. Of those, the majority (60.4%) were women, and 
further, DP was more common in the highest age group (60-64 years). 
The annual incidence of DP varied during the studied years (10, 37). In 2004 (with the so far 
highest incidence of DPs), a total of 68 551 individuals were granted DP. This number 
decreased to 41 003 in 2007 and to 13 144 in 2014. Moreover, there were gender differences 
also regarding incident DP: of all the new DPs granted in 2004, about 60.5% were granted to 
women, with a slightly decrease in gender differences during the following years (58.8% in 
2007 and 56.7% in 2014). 
1.2.2 Factors associated with disability pension  
Several studies have investigated associations between socio-demographic factors and DP in 
general (36, 38-68). Among these, female gender (36, 38, 39, 41, 44, 45, 49, 51, 53, 54, 56, 58, 59, 64), higher 
age (38, 41, 47, 53, 55, 58, 64), lower educational level (41, 46-48, 55, 59, 66, 67), living in rural areas (60, 
61), being unmarried (41, 44, 46-48, 50, 52, 59, 62), and being foreign-born (43, 49, 57, 68) were 
associated with higher DP rates. 
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Also long-term sick leave (17, 69) and inpatient care (36, 45, 70, 71) have been associated with 
higher general DP rates. However, it has not yet been established whether these factors also 
are important for DP among working-aged women and men with a first coronary 
revascularisation. Since many of these factors also have been associated with CVD (72), it 
would be reasonable to also study these in relation to DP among patients with CABG or PCI. 
Most previous studies concerns DP in general, that is, do not include the specific DP 
diagnoses among individuals with CVD diagnoses (41). 
1.2.3 Coronary revascularisation and disability pension 
In Sweden CVD constitutes the third largest diagnostic group for DP, after mental and 
musculoskeletal diagnoses (10, 14). However, there are hardly any studies on DP in relation to 
coronary revascularisation (14-18). These studies are based on smaller samples, including only 
CABG-patients, and the results of DP are not presented stratified by women and men; even if 
it is well known that DP in general is more common among women than among men (36, 38, 
39, 44, 45, 49, 51, 53, 54, 56, 59) and that more men compared to women of working ages, undergo 
these interventions (22, 23). One study from Finland found that 25% of all the patients working 
one year after CABG and who were below 60 years of age at the 10-year follow-up, had DP 
(16). Another Finnish study found that 17% of post-operatively working patients were on DP 
before 60 years of age (15). 
More comprehensive studies including larger populations could increase the scientific 
knowledge on DP among working-aged women and men with coronary revascularisation by 
CABG or PCI, and contribute to the development of strategies for preventive measures 
among specific subgroups of these patients. One way to conduct such studies is using 
nationwide registers. 
1.2.4 Associations between disability pension and mortality 
Previous studies on DP have found higher mortality rates among individuals with both all-
cause and diagnosis-specific DP compared to those not on DP (73-79). This in spite of that 
most DP diagnoses (e.g. musculoskeletal and common mental disorders) seldom are causes 
of death. 
Previous studies on associations between coronary revascularisation and mortality found that 
women have a higher short-term mortality risk (30 days) (26) but a lower long-term mortality 
risk (9 months up to 10 years) compared with men, following coronary revascularisation (26-
29). 
To the best of my knowledge, no studies have so far investigated associations between DP at 
the time of a first coronary revascularisation and the risk of mortality. Since both CVD and 
DP have been associated with higher mortality, it would be of interest both from a clinical, 
individual, and societal perspective to also investigate mortality among patients with CVD, 
treated with CABG and PCI and associations with DP. Such studies could constitute a 
knowledge base for health care regarding identification of the more vulnerable patient groups, 
in need of more individual-based rehabilitation following intervention. 
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1.3 Research approaches 
Research on sickness absence and DP has been conducted from different scientific disciplines 
and different theories and models have been used (80, 81). This research is, for instance, 
performed within medical science, public health, sociology, psychology, or economics, and is 
often based in explanatory models (research models in organisational psychology, theories on 
absence culture, economic and rational selection theories, stress theories, explanatory models 
in medicine and for changes in levels of sickness absence, strain, attitudes, sickness insurance 
system, and labour market condition), elaborating the causes of sickness absence. However, it 
is not possible to synthesise knowledge from the different theoretical perspectives and 
disciplines, into a combined theory explaining the causes of sick leave. Nevertheless, 
together, all these different perspectives contribute with a broader knowledge base in the 
research field of sickness absence. 
Studies on sickness absence (SA), including the long-term SA, that is, DP, can be categorised 
according to: what is studied, study design, type of data and analyses, scientific discipline, 
perspective taken in the research questions, structural level of factors included in the 
analyses, and diagnoses studied (Table 1) (82, 83). In table 1, the items involved in the studies 
of this thesis are marked in bold. That is, two of the studies concern risk factors for DP and 
two possible consequences, in terms of mortality, of DP. One is cross- sectional and the 
others are prospective cohort studies, all based on quantitative analyses of register data. The 
studies are conducted within the realm of medicine and public health using epidemiological 
methods. The research questions are posed from a health care perspective and all the factors 
included in the analyses are at the individual, patient level. All included patients had CVD. 
Also information about their mental and musculoskeletal DP diagnoses is included. 
Table 1. A structure for categorisation of studies of sickness absence/disability pension 
(83). Aspects included in this thesis in bold letters. 
What is studied -Design 
-Data 
-Analyses 
Scientific discipline Perspective 
taken in 
research 
questions 
Structural level 
of factors 
included in the 
analyses 
Diagnoses 
1. Risk factors 
for sickness 
absence or 
disability 
pension 
 
2. Factors that 
hinder or promote 
return to work 
 
3. Consequences 
of ( being) 
sickness 
absent/(on) 
disability 
pension 
 
4. Sickness 
certification 
practice 
 
5. Methods and 
theories 
Study design 
-Cross sectional 
-Longitudinal 
-RCT, CT, etc. 
 
Type of data 
Interview 
Questionnaire 
Register 
Medical files 
Insurance files 
Notes 
Documents 
Video 
Other 
 
Type of analyses 
-Qualitative 
-Quantitative 
Economy 
Law 
Management 
Medicine/Public 
health/Epidemiology 
Philosophy 
Political Science 
Psychology 
Sociology 
 
Others 
That of the: 
-Society 
-Insurance 
-Health care 
-Worksite 
-Family 
-Patient 
-National 
-Local 
-Worksite 
-Health care 
-Family 
-Individual 
All together 
 
Cancer 
CVD 
Infections 
Injuries 
Mental 
Musculoskeletal 
Nervous system 
Pregnancy 
Skin 
 
Others 
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2 Aims 
The general aim of this doctoral thesis was to study general and diagnosis-specific DP, and its 
association with mortality (all-cause and in CVD) among working-aged women and men 
with a first coronary revascularisation in Sweden in 1994-2006, accounting for socio-
demographic and medical factors. 
The specific aims were as follows: 
• To investigate the prevalence of all-cause and diagnosis-specific DP at the time of a 
first coronary revascularisation, accounting for socio-demographic and medical 
factors (study I). 
 
• To investigate the incidence of DP within five years following a first coronary 
revascularisation, accounting for socio-demographic and medical factors (study II). 
 
• To investigate the five-year all-cause mortality within five years following a first 
coronary revascularisation, among patients on DP and not on DP at the time of 
intervention, accounting for socio-demographic and medical factors (study III). 
 
• To investigate the five-year all-cause and CVD mortality within five years following 
a first coronary revascularisation, among different DP-diagnostic groups (CVD, 
musculoskeletal, and mental diagnoses) at the time of intervention, accounting for 
socio-demographic and medical factors (study IV). 
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3 Methods 
The primary study population in this thesis consisted of all patients in Sweden (N=78 153), 
30-65 years of age when undergoing a first coronary revascularisation by either CABG 
(n=28 234), or PCI (n=49 919), during the years 1994-2006. All analyses were based on data 
from the following five nationwide registers: SWEDEHEART (3), the LISA database 
(Statistics Sweden), the MiDAS database (Swedish Social Insurance Agency), the National 
Patient Register, and the Cause of Death Register (both from the National Board of Health 
and Welfare). An overview of the four studies is presented in Table 2, regarding aim, design, 
study population, inclusion criteria, data sources, main outcomes, variables included in the 
studies, and statistical analyses. 
Table 2. Overview of the four studies, based on register data on all patients with coronary 
revascularisation 1994-2003, and 1994-2006 (N=78 153; 21% women) 
 Study I Study II Study III Study IV 
Aim Investigate prevalence of 
all-cause and diagnosis-
specific DP at the time of a 
first coronary 
revascularisation, 
accounting for socio-
demographic and medical 
factors. 
Investigate incidence and risk 
factors for future DP 
following a first coronary 
revascularisation by CABG or 
PCI, among women and men 
in working ages, accounting 
for socio-demographic and 
medical factors. 
Investigate all-cause, and 
diagnosis-specific mortality 
within the five years 
following a first coronary 
revascularisation among 
women and men on and not 
on DP at time of 
intervention, accounting for 
socio-demographic and 
medical factors. 
Investigate associations 
between diagnosis-specific 
DP at time of coronary 
revascularisation and 
mortality (all-cause and in 
CVD) among women and 
men in working ages. 
Design Nationwide, population-
based, cross-sectional 
study  
Nationwide, population-
based, prospective cohort 
study 
Nationwide, population-
based, prospective cohort 
study 
Nationwide, population-
based, prospective cohort 
study 
Study 
population 
N: 65 676 (20% women) N: 34 643 (16% women) N: 70 040 (20% women) N: 61 525 (18% women) 
Inclusion 
criteria 
Having a first coronary 
revascularisation in 
Sweden, during 1994-
2006, when aged: 30-63 
years, and with no old-age 
pension at intervention.. 
Having a first coronary 
revascularisation in Sweden, 
during 1994-2003, when 
aged: 30-63 years, with no DP 
or old-age pension at time of 
intervention, alive 30 days 
after intervention, and with no 
re-intervention within 30 
days. 
Having a first coronary 
revascularisation in 
Sweden, during 1994-2006, 
when aged: 30-64 years, 
and alive 30 days after 
intervention. 
Having a first coronary 
revascularisation in Sweden, 
during 1994-2006, and not 
on DP before 1994, when 
aged: 30-64 years, and alive 
30 days after intervention. 
Data 
sources 
SWEDEHEART, LISA, 
MiDAS, the National 
Patient Register 
SWEDEHEART, LISA, 
MiDAS, the National Patient 
Register, the Cause of Death 
Register 
SWEDEHEART, LISA, 
MiDAS, the National 
Patient Register, the Cause 
of Death Register 
SWEDEHEART, LISA, 
MiDAS, the National Patient 
Register, the Cause of Death 
Register 
Main 
outcomes 
DP at the time of a first 
CABG or PCI 
DP within five years 
following a first CABG or 
PCI  
All-cause mortality within 
five years following a first 
CABG or PCI  
Mortality (all-cause and in 
CVD) within five years 
following a first CABG or 
PCI  
Variables 
included in 
the studies 
Type of intervention, 
gender, age, level of 
education, country of birth, 
living area, year of 
intervention, indication for 
intervention, diabetes 
mellitus at intervention, 
degree of DP, years on DP 
before intervention, DP 
diagnoses. 
Type of intervention, gender, 
age, level of education, living 
area, marital status, country of 
birth, indication for 
intervention, year of 
intervention, re-intervention, 
diabetes mellitus at 
intervention, in-patient care 
within 5 years before 
intervention, sick-leave days 
in the 12 months before 
intervention.  
Type of intervention, 
gender, DP at time of 
intervention, age, level of 
education, country of birth, 
living area, year of 
intervention, indication for 
intervention, diabetes 
mellitus, in-patient care 
within 5 years up to one day 
before intervention, re-
intervention. 
CVD, musculoskeletal, and 
mental DP diagnoses, type of 
intervention, gender, age, 
level of education, indication 
for intervention, diabetes 
mellitus at time of 
intervention, in-patient care 
within 5 years before 
intervention, and re-
intervention within 5 years 
after intervention. 
Statistical 
analyses 
Descriptive statistics , 
logistic regression 
analyses 
Descriptive statistics, Cox 
proportional hazard regression 
analyses 
Descriptive statistics, Cox 
proportional hazard 
regression analyses 
Descriptive statistics, Cox 
proportional hazard 
regression analyses 
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The project was approved by the Regional Ethical Review Board of Stockholm, Sweden 
(2006/661-31). 
3.1 Study design and populations 
In this doctoral thesis, four different studies were conducted: one cross-sectional (study I) and 
three prospective cohort studies (study II-IV). The first study had a cross-sectional design in 
order to investigate the prevalence of DP among patients, 30-63 years of age, at the time of 
their first coronary revascularisation (CABG or PCI) in 1994-2006 in Sweden. This since no 
previous studies had a specific aim to investigate DP among patients undergoing 
revascularisation by CABG or PCI. The three cohort studies investigated: granted DP within 
five years following a first coronary revascularisation (study II), all-cause mortality among 
DPs and non-DPs, within five years following the intervention (study III), and all-cause and 
CVD mortality, among DP-diagnostic groups and non-DPs, within five years following the 
intervention (study IV). 
Study I was a population-based cross-sectional study that comprised 65 676 individuals in 
Sweden, who during 1994-2006, when aged 30-63 years, underwent a first CABG (n=22 
959) or PCI (n=42 717) and were not on old-age pension. 
Study II was a population-based prospective cohort study comprising all patients in Sweden 
(n=34 643) who during 1994-2003, when aged 30-63 years, had a first CABG (n=14 107) or 
PCI (n=20 536), were not on DP or old-age pension at the time of the intervention, and were 
alive and had no re-intervention in the 30 days after intervention. 
Study III was a population-based prospective cohort study comprising all patients in Sweden 
(n=70 040) who during 1994-2006, when aged 30-64 years, had a first CABG (n=24 987) or 
PCI (n=45 053), and were alive within 30 days after intervention. 
Study IV was a population-based prospective cohort study comprising all patients in Sweden 
(n=61 525) who during 1994-2006, when aged 30-64 years, had a first CABG (n=21 093) or 
PCI (n=40 432), were not on DP before 1994, and were alive within 30 days after 
intervention. The reason for only including DPs from 1994 was due to the non-available 
information on DP diagnoses through the MiDAS database before that year. Thus, 8515 
individuals who were granted DP before 1994 were not included in this study. 
3.2 Data 
The study population was identified through the SWEDEHEART-register, held by the 
Uppsala Clinical Research Centre (8) that includes data on e.g., indication and date of 
intervention and whether one had diabetes mellitus at the time of the intervention. Additional 
data were obtained by linkage of four other nationwide registers using the unique 10-digital 
personal identification number assigned to all individuals registered as living in Sweden. The 
linkage was conducted by SCB and de-identified data were delivered to the research group. 
These four registers are described in detail below. 
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3.3 The Swedish Social Insurance Agency 
3.3.1.1 The MiDAS database 
The Swedish Social Insurance Agency has established a register for research regarding 
sickness absence and DP, the Micro Data for the Analysis of Social Insurance (MiDAS) 
database. This database includes information from 1994 regarding sickness absence and DP 
benefits paid by the agency regarding date and degree (full or part time) of sickness absence 
and DP as well as DP diagnoses (DP diagnoses obtained for 1994-2008). Most employees 
have sick pay from their employers during the first 14 days of a sick-leave spell, why 
information on the shorter sick-leave spells for employees are not included in this thesis (84). 
3.4 The National Board of Health and Welfare 
3.4.1.1 The Swedish National Patient Register 
From the Swedish National Patient Register, also called the Hospital Discharge Register, data 
on main diagnoses and dates of in-patient care from 1964 through 2008 was obtained. This 
register was established in 1964. It has a complete coverage from 1987; more than 99% of all 
somatic and psychiatric hospital discharges are included. A validation by the National Board 
of Health and Welfare found that 85-95% of all included diagnoses in this register are valid 
(85). This register includes information on in-patient care (and visits to a physician within 
specialised outpatient care from 2001, not used in this thesis) due to CVD and other diseases 
(86). This is one of the few individual-based registers worldwide, covering in-patient 
healthcare for a whole population. The quality is controlled regularly. The main diagnosis is 
missing for about 1% of all occasions.  
3.4.1.2 The Cause of Death Register 
The Cause of Death Register includes data from 1961 for all deceased individuals, registered 
and living in Sweden at the time of their death, regardless if the death occurred within or 
outside the country. From this register, date of death (through 2007) and cause of death 
(through 2006) was obtained for the included patients. The missing information on cause of 
death has been about 1-2% during the last years (87). 
3.5 Statistics Sweden 
3.5.1.1 The LISA database 
The longitudinal integration database for health insurance and labour market studies (LISA) 
database include annual data on socio-demographic, socio-economic factors and other data 
from 1990, for all individuals, ≥16 years of age, registered as living in Sweden in December 
each year (88). Of those, level of education, marital status, type of living area, country of birth, 
and emigration were obtained and used in the analyses. The included factors are summarised 
in Table 2 and further described in detail below. 
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3.6 Outcome factors 
In study I and II, the main outcomes were all-cause DP (regardless of full- or part-time DP); 
in study I in terms of prevalent DP including DP diagnoses, and in study II in terms of future 
DP. 
In study I, the main outcome was defined as being on DP at the time of a first coronary 
revascularisation by either CABG or PCI, during 1994-2006. All-cause DP was the outcome 
of the logistic regression analyses and diagnosis-specific DP the outcome of the descriptive 
analyses. The DP diagnoses were coded according to the World Health Organizations’ 
(WHO´s) International Classification of Diseases, version 10 (ICD 10) (89). The DP diagnoses 
were classified into CVD (I00-I99), mental (F00-F99), musculoskeletal (M00-M99), other 
DP diagnoses, and missing DP diagnoses. 
In study II, the main outcome was defined as being granted a first DP, regardless of DP 
diagnosis, within five years, or through 2007, following a first coronary revascularisation by 
CABG or PCI during 1994-2003. 
In study III and IV, the main outcomes were all-cause mortality (study III-IV) and mortality 
in CVD (study IV). 
In study III, the outcome was defined as all-cause and cause-specific mortality, within five 
years or at the end of the follow-up, that is through 31 December 2006, following a first 
coronary revascularisation by CABG or by PCI. Those deceased within 30 days following 
intervention were excluded from the study. All-cause mortality was the outcome of the Cox 
regression analyses, and diagnosis-specific mortality the outcome of the descriptive analyses. 
In study IV, the outcome was defined as all-cause mortality and mortality in CVD (ICD 10, 
I00-I99) within five years or through 31 December 2006, following a first coronary 
revascularisation by CABG or PCI. Those deceased within 30 days following intervention 
were excluded from the study. 
3.6.1 Socio-demographic factors 
In all four studies, several socio-demographic factors were included, as descriptive and/or 
independent variables. The following factors were obtained from the SWEDEHEART-
register (age and gender) or from the LISA database (level of education, marital status, type 
of living area, country of birth, and emigration) and are further described below.  
3.6.1.1 Age 
Age at the time of intervention was categorised into four groups: 30-49 (reference group), 50-
54, 55-59, and 60-63 years (study I-II), and 60-64 (study III-IV) and was used as an 
independent variable (study I-IV). 
3.6.1.2 Gender 
Most of the analyses were stratified by gender (study I-IV). Gender was further used as a 
descriptive variable (study I-IV) or an independent variable (study I-II). 
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3.6.1.3 Level of education 
The individuals’ highest attained level of education at the time of the intervention was 
included as a descriptive variable or an independent variable (study I-IV). The original 
variable (SUN2000NIVA) obtained from the LISA database had seven categories; 1. Pre 
high-school level (<9 years), 2. Pre high-school level (9 years), 3. High school, 4. Post high-
school level (<2 years), 5. Post high-school level (≥2 years), 6. Research education, and 7. 
Missing data. In study I, III and IV, these seven categories were merged into three: 
elementary school (≤9 years), high school (9-12 years), and college/university (>12 years), 
respectively. The last category, college/university, was further used as reference group in the 
regression analyses. However, in study II, “college” (referred to post high-school level) 
together with “high school” were included in the category medium level of education. The 
category “missing data” (<1%), was merged with “elementary school” in study I (0.7%, table 
2, 4-5), study III (0.7%, table 4-5), and in study IV (0.9%, table 1-4). 
3.6.1.4 Marital status 
The factor marital status was included in study II, and involved seven different categories 
(unmarried, married, divorced, widow/widower, registered partner, divorced partner, 
widow/widower partner), which were dichotomised into: married and non-married 
(unmarried, divorced, widow/widower, divorced partner and widow/widower partner) and 
used as a descriptive or an independent variable. 
3.6.1.5 Type of living area 
The variable ‘type of living area’, included as a descriptive and an independent variable in 
study I-III, was created by using data on type of municipality in which the patients lived at 
the time of their first intervention. In the Statistics Sweden the definition “H-regions” 
(homogenous regions) were defined by how urban or rural the respective municipality was 
considered. The version of the following six H-regions was used (90): (H1) Stockholm, 
Södertälje, (H2) Göteborg, Malmö, Lund, Trelleborg, (H3) larger cities (>90 000 inhabitants 
within 30 km from the city centre), (H4) middle-sized municipalities (27 000 to 90 000 
inhabitants within 30 km from the city centre, and >300 000 inhabitants within 100 km from 
the same point), (H5) smaller municipalities (27 000 to 90 000 inhabitants within 30 km from 
the municipality centre, and <300 000 inhabitants within 100 km from the same point), and 
finally (H6) rural areas (<27 000 inhabitants within 30 km from the municipality centre). 
These categories were merged into three groups: larger cities (H1-H2) (reference group in 
regression the analyses), medium-sized cities (H3), and smaller communities (H4-H6), also 
called: larger, medium, smaller (study I), and large, medium, small (study III). 
These H-regions, rather than geographical regions, were used due to the assumption that it 
might be easier to change employment due to health problems when living in a more urban 
area. 
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3.6.1.6 Country of birth 
The information on country of birth (study I-III) was divided into ten categories: 00=Sweden, 
01=the Nordic countries (except Sweden), 02= EU25 (except Denmark, Finland, and 
Sweden), 03= Europe (except EU25 and the Nordic countries), 04=Africa, 05=North 
America, 06=South America, 07=Asia, 08=Oceania, 09=Soviet Union, 11=Unknown). These 
were merged into five groups: “Sweden”, “Other Nordic countries”, “Other EU25”, and 
“Other countries” (study II), and dichotomised into: “Sweden” (reference group), versus 
“Other” (study I and III). Country of birth was included both as a descriptive and an 
independent variable (study I-III). 
3.6.1.7 Emigration and old-age pension 
Date of emigration was obtained from the LISA database and used for censoring in the Cox 
regression analyses of study II-IV. Information on old-age pension was obtained from the 
Swedish Social Insurance Agency and LISA. 
3.6.2 Medical factors 
In all four studies, medical factors were included as descriptive and/or independent variables. 
Information on these factors was obtained from the SWEDEHEART-register (year of, and 
indication for the intervention, type of intervention, diabetes mellitus at the time of 
intervention, and re-intervention following the first intervention), the Swedish National 
Patient Register (main diagnoses of in-patient care), and the MiDAS-database (number of 
sick-leave days in the 12 months before the intervention, number of years on DP before the 
intervention, degree of DP). 
3.6.2.1 Year of intervention 
The year of the intervention was included both as a descriptive and an independent variable 
(study I-III) and was categorised as follows: 1994-1996, 1997-2000, 2001-2003, and 2004-
2006 (study I), 1994-1996, 1997-2000, and 2001-2003 (study II), and 1994-1997, 1998-2001, 
and 2002-2006 (study III). The categorisation of years differed in study III due to the fact that 
information on cause of death was not available after 2006, thus, those who had an 
intervention in 2002 and forward were followed for less than five years, and therefore, they 
constituted an own category (year 2002-2006). 
3.6.2.2 Indication for the intervention 
Indication for the intervention was included as a descriptive and/or an independent variable 
(study I-IV) and was categorised according to ICD 10 into: acute coronary syndrome (ACS) 
classified according to electrocardiographic findings as non-ST-segment elevation 
myocardial infarction or ST-segment elevation myocardial infarction, stable angina pectoris, 
and other. 
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3.6.2.3 In-patient care in the five years before the intervention 
Information on main diagnoses for in-patient care in the five years before the intervention 
was included as a descriptive and/or an independent variable (study II-IV) and categorised 
according to ICD 10 into: angina pectoris (I20), myocardial infarction (I21-I22), heart failure 
(I50), cerebrovascular disease (I60-I69), transient cerebral ischaemic attacks (G45), mental 
disorders (F00-F99), and musculoskeletal disorders (M00-M99). The five years were 
calculated in relation to the exact date of the intervention. In the regression analysis of study 
II, CVD (myocardial infarction, heart failure, cerebrovascular decease, and transient cerebral 
ischaemic attacks), and mental, as well as musculoskeletal disorders, were analysed 
separately. In study III-IV all the original diagnoses for in-patient care were dichotomised 
into: “yes” and “no” in-patient care. 
3.6.2.4 Diabetes mellitus at the time of intervention 
Diabetes mellitus at the time of intervention was included as a descriptive and/or an 
independent variable (study I-IV) and was categorised into “yes”, “no”, and “missing data”. 
Information on whether one had diabetes mellitus was missing for 12% of the patients and 
was considered as a separate category in three of the studies (study I and III-IV) and included 
in the non-diabetes category in one of the studies (study II). The reason for the missing data is 
unclear. However, since information on diabetes mellitus was originally collected by the 
physicians asking if the patients had diabetes mellitus at the time of the intervention, a no-
answer might not have been documented at that time point. This could be an explanation for 
why these were merged with the non-diabetes patients in study II. 
3.6.2.5 Re-interventions (one or more) in the five years following the first intervention 
Re-intervention at least once, either by CABG or PCI within the five years following the first 
intervention was included as a descriptive and/or an independent variable in study II-IV, and 
dichotomised into “yes” versus “no”. 
3.6.3 Sick leave and disability pension 
3.6.3.1 Sick-leave days in the twelve months before the intervention 
Information on number of sick-leave days with benefits from the Social Insurance Agency in 
the 12 months before the exact date of the intervention was included in (study II) and 
categorised into: 0, 1-89, 90-179, and 180-365 days. The group with 0 days with benefits 
from the Social Insurance Agency can include shorter sick-leave spells reimbursed by the 
employer. In the regression analyses, the two first groups were combined and used as 
reference group. 
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3.6.3.2 Years on DP before intervention 
Years on DP before the exact date of the intervention were included (study I, III) and 
categorised into three groups: ≤3 years, 4-10 years, and 11-35 years. 
3.6.3.3 Degree of DP 
Degree of DP was included as a descriptive variable (study II). The original variable with six 
degrees of DP was dichotomised into: full-time DP: >50%, and part-time DP: ≤50%. 
3.6.3.4 Diagnoses for DP 
Information on the ICD 10 code of the main DP diagnoses was obtained from the MiDAS 
register. As this register was started up in 1994, information on diagnoses for DP granted 
before 1994 was not included in the register. However, duration and grade of DP could be 
obtained before 1994. DP diagnoses was categorised into the following four groups: CVD 
(ICD-10 code I00-I99), musculoskeletal (M00-M99), mental (F00-F99), and other/missing 
DP-diagnoses at the time of a first coronary revascularisation by CABG or PCI. 
3.7 Statistical analyses 
In all four studies, results from descriptive statistics were presented in frequencies and 
proportions. All the analyses were performed separately for women and men as well as for 
type of intervention (CABG, PCI). 
In study I, logistic regression analyses were performed to analyse the associations between 
socio-demographic and medical factors and the probability of prevalent DP (irrespective of 
full or part-time), among patients 30-63 years of age at the time of their first coronary 
revascularisation (CABG or PCI) in 1994-2006. Crude odds ratios (OR) with 95% confidence 
intervals (CI) were estimated and adjustments were made for age (model I), age, and level of 
education (model II), gender (model III), and age, level of education, country of birth, type of 
living area, year of intervention, indication for intervention, and diabetes mellitus at the time 
of the intervention (model IV).  
Cox proportional hazard regression analyses were performed in study II-IV.  
In study II, Crude and adjusted hazard ratios (HR) with 95% CI were estimated for granted 
DP within five years following a first coronary revascularisation, with regards to socio-
demographic and medical factors as well as previous sick leave, among patients, 30-63 years 
of age at time of their first CABG or PCI in 1994-2003, with no DP or old-age pension at the 
intervention, and no re-intervention within 30 days following the intervention. All patients 
contributed with person time (days at risk) from the date of the first intervention until the date 
of being granted DP, starting old-age pension, emigration, death, or end of follow-up 
(December 2007).The HRs were adjusted for variables in the following models: age, level of 
education, country of birth, and year of intervention (model I), and age, level of education, 
country of birth, year of intervention, and sick-leave days in the 12 months before 
intervention (model II). 
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In study III, crude and adjusted HRs with 95% CI were estimated for all-cause mortality 
within five years following a first coronary revascularisation (1994-2006), among patients, 
alive 30 days following intervention, on all-cause DP compared with those not on DP at the 
time of intervention. The proportional hazard assumption was checked graphically and no 
indication of violation of this assumption was found. All patients contributed with person 
time (days at risk) from the date of the intervention (1994 through 31 November 2006) until 
the date of emigration, death or end of follow-up (December 2006). The HRs were adjusted 
for variables in the following models: age (model I), and age, level of education, country of 
birth, type of living area, year of intervention, indication for intervention, diabetes mellitus at 
time of intervention, in-patient care in the five years before intervention, and re-intervention 
within five years following intervention (model II). 
In study IV, crude and adjusted HRs with 95% CI were estimated for mortality (all-cause and 
in CVD) within five years following a first coronary revascularisation, among patients, alive 
30 days following intervention, on diagnosis-specific DP (CVD, musculoskeletal and mental 
diagnoses), granted from 1994, compared with those not on DP at time of intervention. All 
patients contributed with person time (days at risk) from the date of the first intervention 
(1994 through 31 November 2006) until the date of emigration, death or end of follow-up 
(December 2006). The HRs were adjusted for variables in the following models: age and 
level of education (model I) age, level of education, indication for intervention, diabetes 
mellitus at time of intervention, in-patient care in the five years before intervention, and re-
intervention within five years following the intervention (model II, and III).    
Data on diabetes mellitus were missing for 12% of all the included patients (study I-IV), and 
in study IV all who had been granted DP before 1994 were excluded (n=8515, 12%) due to 
the fact that data on DP-diagnoses was missing before that year. 
All the statistical analyses were performed using IBM SPSS version 20 and 22. 
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4 Results 
Below, general results from each study are presented; more detailed results are found in the 
studies in the appendix for respective study. 
4.1 Study I 
In total, 24% of the patients were on DP at the time of their first coronary revascularisation. 
Musculoskeletal diagnoses were the largest DP-diagnostic group. Among those on DP, 62% 
had had DP for at least four years before the intervention. The following groups had a higher 
adjusted probability of being on DP at the time of the intervention: women (OR: 2.40; 95% 
CI: 2.29-2.50), older individuals (50-63 years); especially 60-63-year old men with CABG 
(OR: 4.91; 95% CI: 4.27-5.66), lower level educated; especially men with PCI (OR: 2.96; 
95% CI: 2.69-3.26), foreign-born; especially men with PCI (OR: 2.11; 95% CI: 1.96-2.27), 
and women with another indication for intervention than ACS or stable angina pectoris for 
PCI (OR: 1.72; 95% CI: 1.31-2.24). 
4.2 Study II 
Of all patients not on DP at the time of their first coronary revascularisation, 32% were 
granted DP within the five years following intervention. Women had higher HR for DP 
compared with men, also after adjustments for age and level of education respectively 
(education-adjusted HR 1.55; 95% CI: 1.48–1.62), and CABG-patients had higher HR for DP 
compared with PCI-patients, also after adjustments for age, and level of education 
respectively (education-adjusted HR 1.35; 95% CI: 1.30–1.40). The highest crude HR was 
found in patients with 180-365 sick-leave days in the 12 months before the intervention, 
especially among men with PCI (HR 6.25; 95% CI: 5.84-6.68). 
4.3 Study III 
Of all patients, 30-64 years of age at time of their first coronary revascularisation during 
1994-2006, 4% died during the five year follow-up or through year 2006; most of them died 
due to CVD. Regardless of adjustments for socio-demographic and medical factors, women 
and men with DP at the time of CABG or PCI had higher HRs for mortality compared with 
those not on DP at the time of intervention (CABG: women HR 2.14; 95% CI 1.59-2.89, men 
HR 2.09; 95% CI: 1.84-2.38, PCI: women HR 2.25; 95% CI: 1.78-2.83, men HR 1.95; 95% 
CI: 1.72-2.21). Higher mortality risks were also found among most of the subpopulations on 
DP at time of intervention compared with those not on DP. 
4.4 Study IV 
Of all patients, 30-64 years of age at time of their first coronary revascularisation, excluding 
those granted DP before 1994, 14% were on DP at the time of their first coronary 
revascularisation. In total, 3.0% of all those patients died; 1.7% due to CVD. Of the patients 
on DP at the intervention, 5.9% died during the five-year follow-up or through year 2006. 
The HR for five-year mortality (all-cause or in CVD) more than doubled among women and 
men on DP due to CVD at time of CABG or PCI, compared with those not on DP at the time 
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of intervention. The included socio-demographic or medical factors (age, level of education, 
indication for intervention, diabetes mellitus at the time of intervention, in-patient care in the 
five years before intervention, and at least one re-intervention in the five years following 
intervention) could not explain the higher associations, except for CVD mortality among 
women on DP due to CVD at time of CABG. 
All studied DP-diagnostic groups (CVD, musculoskeletal and mental diagnoses) were 
associated with higher five-year mortality (all-cause and in CVD), compared with those not 
on DP at intervention – with one exception: CVD mortality among those with mental DP 
diagnoses. However, when presenting gender-specific results, men with mental DP-diagnoses 
at time of PCI had higher HRs for CVD mortality compared with those not on DP. The HRs 
for mortality were particularly high among those with mental DP-diagnoses and all-cause 
mortality at time of intervention, especially women with PCI (HR 3.16; 95% CI: 1.46-6.82). 
The associations could not be explained by age, educational level, or medical factors. 
Moreover, no significant differences in estimated HRs were found between most of the DP-
diagnostic groups (the CIs overlapped).
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5 Discussion 
This thesis covers all individuals of working-ages in Sweden who had a first coronary 
revascularisation of either CABG or PCI over a period of thirteen years (1994-2006). High 
quality data were linked from several nationwide registers and included in the analyses. The 
main results regarding the prevalence and incidence of DP and mortality are initially 
discussed separately for each study. In addition, the main results regarding the studied 
independent variables, and different aspects of the methods are discussed. 
The associations between DP following a first coronary revascularisation and some of the 
possible contributing socio-demographic and medical factors, as well as sick leave in the year 
before intervention were investigated. However, other factors, not included in the analyses 
might contribute to the associations (91). One such possible factor is for instance employment 
status of the studied patients. Since previous studies have found higher probability of being 
granted DP among unemployed individuals (92, 93), this factor could be important to include in 
future studies on DP regarding this population. 
5.1 Discussion of results 
5.1.1 Study I 
Of all investigated patients aged 30-63 years at the time of their first coronary 
revascularisation (1994-2006) by either CABG or PCI, about a quarter (24%) already had 
DP, usually for full time, at their first intervention. More than half of them had been on DP 
since at least four years before the intervention. Hence, many had been outside of the working 
life for many years before the intervention and maybe also before the indexed CVD-
diagnosis. To what extent being on DP can be a risk factor or a risk indicator for future CVD 
is an issue that would be of interest to investigate further in order to get a knowledge base for 
possible preventive actions. 
The proportion of DP in the study population, in 2004 (the year with the highest DP-rate in 
Sweden), was almost twice as high (22%) as the prevalence of DP in the general Swedish 
population, in the same ages, and in the same year (12%) (37). Further, DP was more than four 
times higher in the studied population as in the entire working population of OECD countries 
in 2007 (6%) and in 1990 (5%) (94) and in Sweden in 2007 (9%) (37). However, the studied 
population is different from the general population, in terms of age, gender distribution, and 
having CVD which might lead to loss of function, activity and work capacity. Moreover, 
during the studied years DP rates were much higher compared with DP rates of today (2010-
2015). Therefore, it would be of interest to further investigate present DP prevalence among 
patients with a first coronary revascularisation. 
5.1.2 Study II 
Of all studied patients aged 30-63 years, with no DP at the time of their first CABG or PCI 
(1994-2003), almost a third (32.4%) of the women and men were granted DP within the five-
year follow-up. Among all the studied patients with a revascularisation in 2003, the five-year 
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incidence for DP (3.2%), was more than twice as high as among the general population in the 
same ages, at the same year (1.4%) (37). There is no simple way to explain early exit from the 
labour market among some individuals, when others return to work or to other activities. The 
results of prevalent and incident DP, as well as mortality among patients on DP at the time of 
coronary revascularisation cannot be explained by one single factor, thus the explanations rest 
on a multifactorial ground. More knowledge is warranted on factors that can prevent 
exclusion form the labour market in this group. To gain further knowledge regarding the 
impact of medical factors on future DP in this patient group, further attention on specific DP 
diagnoses at the time of coronary revascularisation was implicated and further investigated in 
study IV.  
5.1.3 Study III 
Of all studied patients aged 30-64 years at the time of their first coronary revascularisation 
(1994-2006), and who were alive one month after the intervention, 4% died (in all-cause 
mortality) within the five-year follow-up (or through 31 December 2006). In accordance with 
previous studies (73-79) and regardless of adjustments, the five-year mortality was more than 
twice as high among both women and men on DP at the time of CABG or PCI compared 
with no DP; also in most of the subpopulations. This result was not explained by the included 
socio-demographic or medical factors.  
However, there might be several other explanations for this association (79); a possible 
explanation could be the underlying disease or other morbidity than the main indication for 
intervention. However, since most of the mortality rates remained high when adjusting for 
medical factors such as in-patient care in the five years before, and re-intervention in the five 
years after the intervention, as well as diabetes mellitus at the time of intervention, this is less 
likely. Nevertheless, data were only available on main diagnosis for in-patient care, therefore, 
other co-morbidity as, for example, the second diagnosis for in-patient care might shed 
additional information on these results. 
This study did not include DP diagnosis in the regression analyses; however, when including 
these as independent variables in study IV (almost the same population as in study III), all the 
three DP-diagnostic groups (CVD, musculoskeletal, and mental diagnoses), also the non-
lethal, were associated with a higher five-year mortality risk compared with no DP at the time 
of the intervention.  
Also, other factors than the disease itself could have contributed to the higher mortality rate 
among DPs, for example: the unfavourable risk factor profile found in previous studies 
among DPs (lower educational level, high alcohol intake, smoking, and not being in a 
relationship) (79). Moreover, the DP could be a negative health factor on top of the underlying 
disease (95). DP in itself might imply risk factors that are associated with the higher mortality 
risk among these patients. The loss of the work-related social network could imply loss of the 
own identity and position in the society. 
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5.1.4 Study IV 
Of the studied women and men aged 30-64 years who were alive 30 days after their first 
coronary revascularisation in 1994-2006 and who were not granted DP before 2004, 3.0% 
died; 1.7% due to CVD. Among the patients on DP at the time of the intervention 5.9% died 
within the five-year follow-up or through 2006. 
All except for mental DP-diagnoses were associated with higher five-year mortality (all-cause 
and in CVD) compared with those not on DP at the time of the intervention – However the 
gender-specific results showed higher mortality risks also among most of the mental DP-
diagnostic groups. The higher mortality risks remained regardless of adjustments for age, 
educational level, and medical factors. Also those with non-lethal DP diagnoses, i.e., 
musculoskeletal diagnoses, had a higher mortality risk. This finding is in line with previous 
studies on DP in the general population (73-79). For example, Björkenstam et al. (73) found that 
also those with non-fatal DP diagnoses still had higher mortality risk, and that previous in-
patient care did not explain this association. Future investigation both regarding other 
possible medical explanatory factors such as co-morbidity, severity of disease, and more 
detailed information on causes of death, as well as factors at other structural levels for 
example: work site and family factors, could further clarify these associations. These factors 
are especially important to regard among patients with DP due to musculoskeletal and mental 
diagnoses at the time of a coronary revascularisation, since previous studies have found 
associations between these disorders and higher risk of CVD (96), between depression and 
higher mortality among patients with MI (97), and between depression before CABG and a 
higher risk of death, heart failure, MI and stroke (98). Furthermore, accelerated cardiovascular 
morbidity and mortality occur in patients with Rheumatoid arthritis who have a high 
prevalence of coronary plaque (99). 
5.1.5 Factors associated with DP and five-year mortality  
5.1.5.1 Type of intervention 
Data in all four studies in this thesis were stratified by type of intervention, that is, by CABG 
or PCI. This was done since patients with CABG often have more severe coronary heart 
disease than PCI patients (5-7, 36), and they might therefore have a higher DP and mortality 
risk. This was also confirmed by the results in this thesis (study I-II); DP was more common 
among patients who had had a first CABG than among those with a PCI. As the choice of 
intervention shifted over the studied years so that PCIs became more common, also year of 
intervention was included in the analyses. 
5.1.5.2 Age 
Among both genders with CABG or PCI, regardless of adjustments, and in accordance with 
previous studies on DP (38, 41, 43, 47, 51, 53, 55, 57, 58, 64, 67, 68, 88, 100-104) older patients, over 50 
years of age, had both higher prevalence and higher five-year incidence of DP compared with 
younger patients (30-49 years) (study I-II); the probability of being on DP at the time of 
intervention was more than fourfold higher among the oldest men (60-63 years). However, 
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this was only slightly above the DP rates of men in the general Swedish population in the 
same age group (30% versus 27% respectively) (37). The finding of higher DP rates among 
older individuals may be explained by an increasing morbidity with age. The result of 
incident DP was not adjusted for medical factors. However, when taking medical factors 
(year of intervention, indication for intervention and diabetes mellitus) into account the 
associations between all age groups and prevalent DP increased; this remains unexplained. 
Another explanation of the higher DP rates among older patients could be the high 
employment rate among older individuals in Sweden, and that a higher rate of those in the 
older group had a lower level of education. Lower educational level often implies jobs with 
higher DP risks, less possibilities to find alternative jobs if one is not capable of handle the 
demands of the present jobs, and might also imply less coping strategies (64, 105). 
Younger patients (30-49 years) (study III-IV) on DP at the time of the intervention had a 
markedly higher five-year mortality (more than a fourfold higher), compared with younger 
patients not on DP. After adjustments for socio-demographic factors (age, level of education, 
country of birth, or type of living area) and medical factors (year of intervention, indication 
for intervention, diabetes at the time of intervention, in-patient care in the five years before 
intervention, and ≥1 re-intervention), the HR for mortality remained high. The exception to 
that were women on DP at the time of CABG, for whom these factors explained the whole 
association. The finding of higher mortality among younger DP recipients is in accordance 
with another study on general DP (79). Apparently, DP or factors associated with DP at the 
time of intervention seem to highly influence the five-year mortality among younger patients. 
However, this finding needs further research. 
5.1.5.3 Gender 
In line with several previous studies on DP, in general and regarding musculoskeletal and 
mental diagnoses, (36, 38, 39, 41, 44, 45, 49, 51, 53, 54, 56, 58, 59, 64, 80, 106) women had both higher 
prevalent and incident DP compared with men. Women in both the intervention groups 
(CABG, PCI) had higher DP rates, also when adjusting for age and educational level. There 
are several theories about this (80, 107). Probable explanations or contributing factors for this 
could be women’s higher age when being diagnosed with CVD (24), and that women have 
smaller coronary arteries and more co-morbidity than men (2). Other explanations are 
women’s higher sick-leave rate (108), different demands at work, and possible gender bias in 
health care (80, 107, 109). 
5.1.5.4 Level of education 
In the analyses of this thesis, irrespective of type of intervention and gender, lower level of 
education (≤12 years) was found to be associated with a higher prevalent and incident DP 
compared with having higher level of education (>12 years). Individuals with at the most 
elementary education had up to tripled odds for being on DP at the time of intervention, and 
were up to two times more likely to be granted DP in the five years following the 
intervention. These findings are in accordance with previous studies (41, 46-48, 55, 59, 66, 67) and 
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also in line with findings of higher educational level as a protective factor for DP in general 
(51, 110). 
5.1.5.5 Country of birth 
The patients with coronary revascularisation, who were born outside Sweden, had both higher 
prevalent and incident DP (study I-II) compared with the patients born in Sweden. Men born 
outside of Sweden had a particularly higher probability of being on DP, both at time of 
CABG or PCI compared with the men born in Sweden. These results remained when 
adjusting for the included socio-demographic and medical factors (study I). These findings 
are in line with previous studies on DP in general (43, 57, 68, 100). 
5.1.5.6 Sick-leave days in the twelve months before the intervention 
Patients, both women and men, with more than 180 sick-leave days in the 12 months before 
the CABG or the PCI had the highest risk estimates for DP granted in the following five 
years, compared with those who had less than 90 sick-leave days before the interventions. 
Men with more than 180 sick-leave days before PCI had a six-fold higher risk of DP in the 
five years following the intervention. This result is in accordance with previous studies (17, 69). 
As DP, in most cases, is granted to individuals with a history of long-term sickness absence, 
this result was to some extent expected. Nevertheless, most people who are sickness absent, 
even for >180 days, are not granted DP. However, in this group, about 20% of those sickness 
absent for >180 days in the year before intervention were not granted DP. 
5.1.5.7 In-patient care in the five years before the intervention 
A higher risk for five-year incidence of DP following a first coronary revascularisation was 
found among patients with previous in-patient care for mental and/or musculoskeletal 
disorders. The higher risk remained when adjusting for socio-demographic factors and 
previous sick-leave (age, level of education, country of birth, year of intervention, and sick-
leave days in the 12 months before intervention). This is in line with previous study findings 
on DP among other studied individuals than those with coronary revascularisation (36, 45, 54, 
71). Furthermore, both women and men on DP at the time of CABG or PCI who had had in-
patient care in the five years before the intervention had higher risk of five-year mortality 
compared with those not on DP at the time of the intervention. These results remained when 
adjusting for the included socio-demographic and medical factors (age, level of education, 
country of birth, type of living area, year of intervention, indication for intervention, diabetes 
mellitus at the time of intervention, and re-intervention). This indicates that the history of 
morbidity before coronary revascularisation is important for prevalence of DP at the time of 
intervention as well as for mortality following the intervention. 
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5.2 Methodological considerations 
In this thesis one cross-sectional and three prospective cohort studies, based on register data 
have been conducted. Below, some methodological aspects of these studies are discussed. 
5.2.1 Strengths 
Main strengths of this thesis are the large study population, that all, not a sample were 
included, the wide set of included data, the high quality of most of the included factors, the 
long follow-up time, and that there were no losses to follow-up. 
The included studies are the first nationwide, population-based studies investigating DP and 
mortality among DPs among both women and men in working-ages at the time of their first 
coronary revascularisation including both CABG and PCI, within a time period of up to 13 
years. Further strengths are the population-based and prospective study designs, the high 
quality data linked together from several nationwide registers, including extensive 
information on medical and socio-demographic factors (85).  
5.2.2 Limitations 
A limitation in this thesis is that not all data on medical factors were complete, e.g., regarding 
diabetes mellitus (information was missing for 12% of the patients). However, since there is a 
strong association between diabetes mellitus and CVD, and these two diagnoses generally 
share the same risk factors (111); it was, nevertheless, important to include this medical factor 
in the studies. Missing data was regarded as an own category, both in the analyses and in the 
descriptive statistics (study I, III-IV). The data on diabetes mellitus, obtained from 
SWEDEHEART, was reported by the physicians who asked the patients about this diagnosis 
prior to the intervention. The reason for missing data on this is unclear. One explanation 
could be that physicians did not register those without diabetes at the time of the intervention. 
For some of the patients, information on diabetes mellitus could be obtained from the Patient 
Register. 
Having had more than 180 sick-leave days in the year before the intervention was associated 
with a particularly high five-year risk of DP following the intervention. During the late 1990s 
and the early 2000 there was no limit to the duration of a sick-leave spell in Sweden, why 
some might have been on sick-leave for many years. In other countries they might have been 
granted DP earlier in the work disability trajectory. This means that some of the results, 
regarding prevalence of DP, incidence of DP, and mortality following DP might be 
underestimated. One way to handle this in future studies could be to define long-term sick-
leave spells, e.g., those lasting for more than two years, as also being on DP (112). 
Additional limitation is the shorter follow-up time among patients with the intervention in 
2003 (study II), and 2002-2006 (study III-IV). This since DP data only were available 
through 2007 (study II) and mortality data through 2006 (study III-IV). Due to this limitation, 
the risk of DP (study II) and mortality (study III-IV) might have been underestimated. 
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When the analyses of study III and IV were stratified for many factors, the size of some 
subpopulations became small and generated rather wide confidence intervals. Mostly, wide 
CIs were found among women in these subpopulations, as the numbers of women were low. 
Most studies on DP do not have access to information on DP diagnosis. In this thesis such 
information could be included, which is a strength. However, data on DP diagnoses was not 
available before 1994. Hence, this data was treated as a no-information category in study I. In 
study IV, individuals granted DP before 1994 were excluded. Many of the excluded 
individuals were in higher ages at the time of the intervention. Since higher age is a risk 
indicator for DP (113), the exclusion of these individuals might have contributed to an 
underestimation of the mortality risk among the DPs.  
Even if excluding those with no information on DP diagnoses before 1994 (study IV), 
information on DP diagnoses was still missing for 15% of those on DP. These could have 
been in one of the three included DP-diagnostic groups. Hence, the HRs of the three groups 
could have been underestimated. 
The validity of DP diagnoses is sometimes questioned; however, it has not yet been studied. 
To the best of my knowledge, only one study investigated the validity of sick-leave diagnoses 
compared with diagnoses in medical files. That study found that the validity was good (114). 
External validity concerns to what extend the results of a study can be generalised to the 
general population (115). The studies included in this thesis are all population-based and have 
relatively high statistical power. The patients included in the four studies were all aged 30-64 
years of age, at the time of their first coronary revascularisation. Hence, the results might not 
be generalizable to other age groups. Moreover, it may be possible that changes of the public 
social insurance system with somewhat altered rules, as well as changes in the extent to 
which the Social Insurance officers adhere to the regulations, means that caution should be 
taken in generalising the results to other time periods than those studied. Furthermore, this 
thesis involves interventions conducted over a long time period, from 1994-2006. Since 
CABG and PCI have improved and changed over time, caution should also be taken when 
generalizing results to present time. 
 
5.3 In summary 
• About one quarter of working-aged patients who had a first coronary 
revascularisation sometime during 1994-2006 were already on DP at the time of 
intervention. 
• The most common DP diagnoses among them were musculoskeletal diagnoses. More 
than half of those on DP at the time of intervention had been so for at least four years. 
• Female gender, older age, lower educational level, and being born outside Sweden 
were associated with a higher prevalence of DP at the time of the first coronary 
revascularisation. The studied socio-demographic and medical factors could not 
explain these associations. 
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• A third of all the working-aged patients who had their first coronary revascularisation 
sometime during 1994-2003, were granted DP within five years following the 
intervention. 
• Women, CABG-patients, long-term sick leave in the year before the intervention, in-
patient care for mental or musculoskeletal disorders in the five years before the 
intervention, diabetes mellitus at the time of intervention, and having at least one re-
intervention within five following years, were associated with higher risk of DP 
within five years following intervention.  
• Four percent of all working-aged patients who had their first coronary 
revascularisation in 1994-2006, died within five years following the intervention; 
most of them due to CVD. 
• DP at the time of intervention was associated with higher risk of five-year mortality, 
compared with no DP, overall as well as in most of the studied sub-populations. The 
studied socio-demographic and medical factors could not explain these associations. 
• All studied DP-diagnostic groups (CVD, musculoskeletal, and mental diagnoses) 
were associated with higher risk of five-year mortality, compared to those not on DP 
at the intervention; also DP diagnoses that in themselves rarely are causes of death 
e.g., musculoskeletal diagnoses. These associations did not differ between DP-
diagnostic groups, except for “all” with CVD or musculoskeletal DP diagnoses at 
PCI, and all-cause mortality. 
 
5.4 Future research 
The prevalence and incidence of DP among patients with a first coronary revascularisation 
seemed to be higher than among those in the general population, indicated by the national DP 
statistics. The prevalence and incidence of DP was high in Sweden during the years studied 
of this thesis. Further, the interventions (CABG and PCI) have been improved over the past 
decades (14). Therefore, to get a picture of the DP situation among patients with a coronary 
revascularisation of today, it would be fruitful to also study DP in present time. 
More than half of the patients had been on DP for at least 4 and up to 35 years before the 
intervention. Although the indication for the intervention was CVD; more were on DP due to 
musculoskeletal DP diagnoses, in general as well as in most of the studied subgroups. This 
implies that many had been outside the labour market for many years before the intervention. 
Maybe musculoskeletal disorders, that were so severe that they lead to DP, could be 
associated with the CVD in itself. Another possibility is that being on DP in itself is either a 
risk factor or a risk indicator for CVD. This indicates that the patients’ medical history, 
beyond CVD, is of importance for those undergoing coronary revascularisation, hence future 
studies could focus on co-morbidity among patients who had had long-term DP before their 
first CABG or PCI. 
Women were associated with both higher prevalent and incident DP in the studied 
population, regardless of age or level of education. This could be due to that women have 
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smaller coronary arteries than men and that the intervention procedures are still not optimal 
for women. Also, women’s higher sick-leave rate, other work arenas and demands, and 
possible other gender bias in health care could contribute to the higher DP rates in women. 
These gender differences show the importance of conducting gender-specific studies on DP 
in this patient group, in order to gain knowledge on possible mechanisms in both women and 
men. 
Many socio-demographic factors were associated with DP in relation to coronary 
revascularisation at the time of intervention. Of these, several have also been associated with 
DP in the general population. 
So far, only few studies have investigated the association between DP and mortality. In this 
thesis, the risk of both all-cause and cause-specific (CVD, musculoskeletal and mental 
diagnoses) five-year mortality was higher among patients on DP, compared with those not on 
DP at the time of intervention, also among most of the included subpopulations. These risks 
remained regardless of adjustments for socio-demographic and medical factors. Therefore, in 
future studies it would be justified to also include other factors such as employment status 
before intervention, severity of disease at the time of intervention, as well as other multi- or 
co-morbidity factors, in order to be able to more in detail explain these associations. 
The scientific knowledge on the consequences of being on DP is limited. However, this thesis 
found a higher five-year mortality risk among patients in all studied DP-diagnostic groups 
(CVD, musculoskeletal and mental diagnoses) compared with those not on DP at the time of 
coronary revascularisation. Hence, the risk was also higher among DP diagnoses considered 
as non-lethal. This is in line with previous studies on DP in general and the risk of mortality. 
Furthermore, the all-cause mortality-risk was markedly higher among mental DP diagnoses, 
than among no DP at the time of intervention; over three times higher among women with 
PCI. This in spite of adjustments for age, level of education and medical factors (indication 
for intervention, diabetes mellitus at the time of intervention, in-patient care in the five years 
before intervention, and re-intervention in the five years following intervention). To further 
explain these associations, future studies may regard other medical factors, for example: 
history of other co-morbidity, such as, the second DP diagnosis, or the second diagnosis for 
in-patient care before intervention. 
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